Evidence map›Paper›PMID 26894828›Full record

ArticlePloS one2016

Agent Based Modeling of Human Gut Microbiome Interactions and Perturbations.

Tatiana Shashkova, Anna Popenko, Alexander Tyakht, Kirill Peskov, Yuri Kosinsky, Lev Bogolubsky, Andrei Raigorodskii, Dmitry Ischenko, Dmitry Alexeev, Vadim Govorun

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Modeling approaches for probing cross-feeding interactions in the human gut microbiome.Computational and structural biotechnology journal · 2022
    Review
  12. Article
  13. Review
  14. Review
  15. Synthetic gut microbiome: Advances and challenges.Computational and structural biotechnology journal · 2021
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Quantifying the impact of treatment history on plasmid-mediated resistance evolution in human gut microbiota.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Tatiana ShashkovaResearch Institute of Physical Chemical Medicine, Malaya Pirogovskaya, 1a, Moscow, 119435, Russia.
Anna PopenkoResearch Institute of Physical Chemical Medicine, Malaya Pirogovskaya, 1a, Moscow, 119435, Russia.
Alexander TyakhtResearch Institute of Physical Chemical Medicine, Malaya Pirogovskaya, 1a, Moscow, 119435, Russia.
Kirill Peskov"M&S Decisions" LLC, Narishkinskaya alleya, 5, Moscow, 125167, Russian Federation.
Yuri Kosinsky"M&S Decisions" LLC, Narishkinskaya alleya, 5, Moscow, 125167, Russian Federation.
Lev BogolubskyYandex LLC 16 Leo Tolstoy St., Moscow, 119021, Russian Federation.
Andrei RaigorodskiiYandex LLC 16 Leo Tolstoy St., Moscow, 119021, Russian Federation.
Dmitry IschenkoResearch Institute of Physical Chemical Medicine, Malaya Pirogovskaya, 1a, Moscow, 119435, Russia.
Dmitry AlexeevResearch Institute of Physical Chemical Medicine, Malaya Pirogovskaya, 1a, Moscow, 119435, Russia.
Vadim GovorunResearch Institute of Physical Chemical Medicine, Malaya Pirogovskaya, 1a, Moscow, 119435, Russia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIntestinal microbiota plays an important role in the human health. It is involved in the digestion and protects the host against external pathogens. Examination of the intestinal microbiome interactions is required for understanding of the community influence on host health. Studies of the microbiome can provide insight on methods of improving health, including specific clinical procedures for individual microbial community composition modification and microbiota correction by colonizing with new bacterial species or dietary changes. METHODOLOGY/PRINCIPAL

findingsIn this work we report an agent-based model of interactions between two bacterial species and between species and the gut. The model is based on reactions describing bacterial fermentation of polysaccharides to acetate and propionate and fermentation of acetate to butyrate. Antibiotic treatment was chosen as disturbance factor and used to investigate stability of the system. System recovery after antibiotic treatment was analyzed as dependence on quantity of feedback interactions inside the community, therapy duration and amount of antibiotics. Bacterial species are known to mutate and acquire resistance to the antibiotics. The ability to mutate was considered to be a stochastic process, under this suggestion ratio of sensitive to resistant bacteria was calculated during antibiotic therapy and recovery. CONCLUSION/SIGNIFICANCE: The model confirms a hypothesis of feedbacks mechanisms necessity for providing functionality and stability of the system after disturbance. High fraction of bacterial community was shown to mutate during antibiotic treatment, though sensitive strains could become dominating after recovery. The recovery of sensitive strains is explained by fitness cost of the resistance. The model demonstrates not only quantitative dynamics of bacterial species, but also gives an ability to observe the emergent spatial structure and its alteration, depending on various feedback mechanisms. Visual version of the model shows that spatial structure is a key factor, which helps bacteria to survive and to adapt to changed environmental conditions.

Indexed as

Gastrointestinal MicrobiomeMicrobial InteractionsModels, BiologicalAlgorithmsAnti-Bacterial AgentsBacteriaDrug Resistance, BacterialHumansMutationAnti-Bacterial Agents

Identifiers

PMID26894828
PMCPMC4760737

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.